Безопасен ли chitosan lauramide succinamide при беременности?
No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
Related ingredients
Frequently asked questions
- Безопасен ли chitosan lauramide succinamide при беременности?
- No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
- Безопасен ли chitosan lauramide succinamide при грудном вскармливании?
- No data located indicating reproductive or lactation-related hazard, no harmonised classification, and no SCCS/CIR contraindication for breastfeeding. Topical cosmetic use of polymeric chitosan derivatives typically shows low systemic absorption; no studies found showing transfer into breast milk for this derivative.
- Безопасен ли chitosan lauramide succinamide для кожи малыша?
- No specific infant-skin safety or absorption studies were located for chitosan lauramide succinamide. Following your scoring rules, because there is measurable (but low) potential for topical absorption for modified chitosan derivatives and infants have higher surface-area-to-weight and immature barrier, exposure (e) is increased by +1 vs adult (from 0 to 1). No infant-specific hazard or mechanism evidence was found to raise h or m.
- Как VeriMom оценивает chitosan lauramide succinamide?
- VeriMom оценивает chitosan lauramide succinamide в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы chitosan lauramide succinamide при беременности?
- См. наш список безопасных альтернатив chitosan lauramide succinamide с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.